Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review

被引：3

作者：

Tarafdar, Nawar ^{[1
]}

Sachdeva, Muskaan ^{[2
]}

Savinova, Iryna ^{[3
]}

Lytvyn, Yuliya ^{[2
]}

Maliyar, Khalad ^{[2
]}

Georgakopoulos, Jorge R. ^{[2
]}

Mufti, Asfandyar ^{[2
]}

Yeung, Jensen ^{[2
,4
]}

机构：

[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada

[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada

[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada

[4] Womens Coll Hosp, Div Dermatol, 76 Grenville St, 5th Floor, Toronto, ON, Canada

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 90卷 / 02期

关键词：

atezolizumab; camrelizumab; cemiplimab; durvalumab; immune checkpoint inhibitor; immunotherapy; ipilimumab; nivolumab; pembrolizumab; psoriasis; systematic review;

D O I：

10.1016/j.jaad.2023.09.070

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：392 / 395

页数：4

共 50 条

[21] Immune checkpoint inhibitor therapy-associated encephalitis: a case series and review of the literature [J].

Stuby, Johann ;

Herren, Thomas ;

Schwegler, Naumburger Guido ;

Papet, Claudia ;

Rudiger, Alain .

SWISS MEDICAL WEEKLY, 2020, 150

[22] The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis [J].

Tandon, Parul ;

Bourassa-Blanchette, Samuel ;

Bishay, Kirles ;

Parlow, Simon ;

Laurie, Scott A. ;

McCurdy, Jeffrey D. .

JOURNAL OF IMMUNOTHERAPY, 2018, 41 (03) :101-108

[23] Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy: A Review [J].

Brown, Alexandria M. ;

Masterson, Wylie ;

Lo, Jonathan ;

Patel, Anisha B. .

DERMATITIS, 2023, 34 (03) :201-208

[24] Association of vitiligo with immune- checkpoint inhibitor therapy: A systematic review [J].

Fleshner, Lauren ;

Roster, Katie ;

Xie, Lillian ;

Lipner, Shari R. .

JAAD INTERNATIONAL, 2025, 18 :119-121

[25] Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases [J].

Suheil Albert Atallah-Yunes ;

Anis John Kadado ;

Gregory P. Kaufman ;

Jaime Hernandez-Montfort .

Journal of Cancer Research and Clinical Oncology, 2019, 145 :1527-1557

[26] Nephrotoxicity of immune checkpoint inhibitor therapy: a pharmacovigilance study [J].

Haeuser, Lorine ;

Marchese, Maya ;

Cone, Eugene B. ;

Noldus, Joachim ;

Bayliss, George ;

Kilbridge, Kerry Laing ;

Quoc-Dien Trinh .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (07) :1310-1316

[27] Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy [J].

Failing, Jarrett J. ;

Dudek, Olivia A. ;

Acevedo, Julian A. Marin ;

Chirila, Razvan M. ;

Dong, Haidong ;

Markovic, Svetomir N. ;

Dronca, Roxana S. .

FUTURE ONCOLOGY, 2019, 15 (22) :2645-2656

[28] Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review [J].

Nidamanuri, Priya ;

Drappatz, Jan .

JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (02) :271-276

[29] Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review [J].

Priya Nidamanuri ;

Jan Drappatz .

Journal of Neuro-Oncology, 2022, 157 :271-276

[30] Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events [J].

Shatila, Malek ;

Zhang, Hao Chi ;

Thomas, Anusha Shirwaikar ;

Machado, Antonio Pizuorno ;

Naz, Sidra ;

Mittal, Nitish ;

Catinis, Christine ;

Varatharajalu, Krishnavathana ;

Colli Cruz, Carolina ;

Lu, Eric ;

Wu, Deanna ;

Brahmer, Julie R. ;

Carbonnel, Franck ;

Hanauer, Stephen B. ;

Lashner, Bret ;

Schneider, Bryan ;

Thompson, John A. ;

Obeid, Michel ;

Farris, David P. ;

Wang, Yinghong .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)

← 1 2 3 4 5 →